CRISPRi/dCpf1-mediated dynamic metabolic switch to enhance butenoic acid production in Escherichia coli
- 27 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Applied Microbiology and Biotechnology
- Vol. 104 (12), 5385-5393
- https://doi.org/10.1007/s00253-020-10610-2
Abstract
Butenoic acid is a short-chain unsaturated fatty acid and important precursor for pharmaceutical and other applications. Heterologous thioesterases are able to convert a fatty acid biosynthesis intermediate in Escherichia coli to butenoic acid. In order to acquire high titer and yield of the product, dynamically switching the metabolic flux from fatty acid biosynthesis pathway to butenoic acid is critical after achieving enough cell mass of the host. A previous developed switch for butenoic acid fermentation is based on triclosan molecule as the FabI inhibitor in the fatty acid biosynthesis cycle. However, triclosan is toxic to human, which may limit its pharmaceutical application. Alternatively, we here purposed a nontoxic switch of carbon flux by harnessing recently developed CRISPR interference (CRISPRi) approach. In our work, we constructed a CRISPRi/dCpf1-mediated dynamic metabolic switch to separate the host growth and production phase via switching the expression of the fabI gene in fatty acid biosynthesis pathway. After optimizing the programmable targets, the CRISPRi-based switch boosted the titer of butenoic acid by 6-fold (1.41 g/L) in fed-batch fermentation. Our work supported that the CRISPRi/dCpf1 switch could replace triclosan-based switch as a nontoxic switch for butenoic acid production, and outcompeted the later switch in the biomass accumulation of the host cell. Moreover, the CRISPRi/dCpf1 system was integrated into the chromosome of the host to improve its genetic stability for long-term fermentation and other applications. Key Points • A programmable metabolic switch was developed to replace the toxic chemical switch to separate the growth phase and production phase of the butenoic acid. • The programmable CRISPRi/dCpf1 switch was efficiently and stably integrated into the host genome to increase their genetic stability during fermentation. • The optimized metabolic switch simultaneously increased the host biomass and butenoic acid titer, and solved the paradox of the competition between growth and production.Keywords
This publication has 36 references indexed in Scilit:
- Engineering Escherichia coli for malate production by integrating modular pathway characterization with CRISPRi‐guided multiplexed metabolic tuningBiotechnology & Bioengineering, 2017
- The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNANature, 2016
- Corynebacterium glutamicum Metabolic Engineering with CRISPR Interference (CRISPRi)ACS Synthetic Biology, 2016
- Triclosan: Current Status, Occurrence, Environmental Risks and Bioaccumulation PotentialInternational Journal of Environmental Research and Public Health, 2015
- Dynamic knockdown of E. coli central metabolism for redirecting fluxes of primary metabolitesMetabolic Engineering, 2015
- Engineered reversal of the β-oxidation cycle for the synthesis of fuels and chemicalsNature, 2011
- The Moderately Efficient Enzyme: Evolutionary and Physicochemical Trends Shaping Enzyme ParametersBiochemistry, 2011
- Novel, Versatile, and Tightly Regulated Expression System for E scherichia coli StrainsApplied and Environmental Microbiology, 2010
- Improving lycopene production in Escherichia coli by engineering metabolic controlNature Biotechnology, 2000
- [26] A T5 promoter-based transcription-translation system for the analysis of proteins in Vitro and in VivoMethods in Enzymology, 1987